Stefan Petry

USPTO Granted Patents = 38 (Patent Applications = 8)

EPO Patents = 16 (Patent Applications = 7)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 112(Granted Patents)

Location History:

Kelkheim, DE (2006 - 2013)
Frankfurt-am-Main, DE (2002 - 2021)

Company Filing History:

11 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

California Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2002-2021

where 'Filed Patents' based on already Granted Patents

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11090364 - Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein (2021-08-17),

2. 9966443 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes (2018-05-08),

3. 9960238 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes (2018-05-01),

4. 9070733 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes (2015-06-30),

5. 9029400 - 5-oxoisoxazoles as inhibitors of lipases and phospholipases (2015-05-12),

6. 8933024 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2015-01-13),

7. 8921404 - Azole derivatives in the form of lipase and phospholipase inhibitors (2014-12-30),

8. 8735437 - Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors (2014-05-27),

9. 8357698 - Diacyl indazole derivatives as lipase and phospholipase inhibitors (2013-01-22),

10. 8148395 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2012-04-03),

11. 8008331 - Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors (2011-08-30),

12. 7968719 - Indazole derivatives as inhibitors of hormone sensitive lipase (2011-06-28),

13. 7897625 - Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases (2011-03-01),

14. 7897616 - Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases (2011-03-01),

15. 7846943 - Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors (2010-12-07),

Title: Stefan Petry - Innovative Inventor from Frankfurt-am-Main

Introduction: Stefan Petry is a renowned inventor based in Frankfurt-am-Main, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Stefan Petry holds several recent patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in the industry, Stefan Petry has a proven track record of turning innovative ideas into successful products. His work has significantly impacted the fields of clean energy, smart infrastructure, and digital healthcare.

Collaborations: Throughout his career, Stefan Petry has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Stefan Petry's passion for innovation and his dedication to solving complex challenges have established him as a key figure in the world of inventors. His continued pursuit of excellence promises a future filled with groundbreaking inventions that will shape the world for years to come.

This text is generated by artificial intelligence and may not be accurate.